LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220K904. A total of 3 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $285,000 | -9.2% | 2,500 | 0.0% | 0.16% | -12.4% |
| Q1 2019 | $314,000 | -54.2% | 2,500 | 0.0% | 0.19% | -54.0% |
| Q3 2018 | $686,000 | +32.4% | 2,500 | 0.0% | 0.40% | +21.3% |
| Q2 2018 | $518,000 | +25.4% | 2,500 | 0.0% | 0.33% | +24.3% |
| Q1 2018 | $413,000 | +20.8% | 2,500 | 0.0% | 0.27% | +22.9% |
| Q4 2017 | $342,000 | +0.6% | 2,500 | 0.0% | 0.22% | -7.2% |
| Q3 2017 | $340,000 | +11.8% | 2,500 | 0.0% | 0.24% | +7.3% |
| Q2 2017 | $304,000 | +14.7% | 2,500 | 0.0% | 0.22% | +11.2% |
| Q1 2017 | $265,000 | +4.3% | 2,500 | 0.0% | 0.20% | 0.0% |
| Q4 2016 | $254,000 | – | 2,500 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 5,300 | $282,000 | 0.00% |
| Citadel Advisors | 10,600 | $564,000 | 0.00% |